ClinicalTrials.Veeva

Menu

D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure (D-Dimer)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Cerebral Infarction
Cerebral Infarction Recovery

Treatments

Biological: blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT04938479
PI2020_843_0159

Details and patient eligibility

About

Cerebral infarction is the leading cause of acquired disability in adults. Absence of biological marker used in current practice and identified as a prognostic factor for recovery. D-dimers are degradation products of stabilized fibrin translating an activation of coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients with MI is associated with a higher mortality rate, the link with post-intervention non-revascularization has been demonstrate.

The purpose of this project is to search for a correlation between the level of D-dimer and the degree of recovery evaluated by the NIHSS score

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 18 to 65
  • Cerebral infarctions undergoing a revascularization procedure by thrombolysis and / or thrombectomy, at the Amiens University Hospital between January 2015 and December 2020.
  • Patients having benefited from a D-dimer assay (during their stay)

Exclusion criteria

Trial contacts and locations

1

Loading...

Central trial contact

Audrey ARNOUX-COURSELLE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems